These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15361261)

  • 1. What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors?--Protocol of a systematic review.
    Scharplatz M; Puhan MA; Steurer J; Bachmann LM
    BMC Med Genet; 2004 Sep; 5():23. PubMed ID: 15361261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of coronary in-stent restenosis: importance of angiotensin-converting enzyme gene polymorphism and treatment with angiotensin-converting enzyme inhibitors.
    Jørgensen E; Kelbaek H; Helqvist S; Jensen GV; Saunamäki K; Kastrup J; Havndrup O; Bundgaard H; Kyst Madsen J; Christiansen M; Andersen PS; Reiber JH
    J Am Coll Cardiol; 2001 Nov; 38(5):1434-9. PubMed ID: 11691520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacogenetic analysis of the effect of angiotensin-converting enzyme inhibitor on restenosis after percutaneous transluminal coronary angioplasty.
    Okamura A; Ohishi M; Rakugi H; Katsuya T; Yanagitani Y; Takiuchi S; Taniyama Y; Moriguchi K; Ito H; Higashino Y; Fujii K; Higaki J; Ogihara T
    Angiology; 1999 Oct; 50(10):811-22. PubMed ID: 10535720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
    Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
    Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
    Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
    Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and ACE inhibitor-related cough: a meta-analysis.
    Li YF; Zhu XM; Liu F; Xiao CS; Bian YF; Li H; Cai J; Li RS; Yang XC
    PLoS One; 2012; 7(6):e37396. PubMed ID: 22723835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction between angiotensin-converting enzyme gene insertion/deletion polymorphism and angiotensin-converting enzyme inhibition on survival in hemodialyzed patients.
    Kiss I; Ambrus C; Kulcsár I; Szegedi J; Kerkovits L; Tislér A; Kiss Z;
    Medicine (Baltimore); 2014 Dec; 93(28):e315. PubMed ID: 25526485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin converting enzyme gene insertion/deletion polymorphism and cardiovascular disease: therapeutic implications.
    Niu T; Chen X; Xu X
    Drugs; 2002; 62(7):977-93. PubMed ID: 11985486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
    Vegter S; Perna A; Hiddema W; Ruggenenti P; Remuzzi G; Navis G; Postma MJ
    Pharmacogenet Genomics; 2009 Sep; 19(9):695-703. PubMed ID: 19696696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin-1 and vasopressin plasma levels are not associated with the insertion/deletion polymorphism of the human angiotensin I-converting enzyme gene in patients with coronary artery disease.
    Al-Fakhri N; Linhart RE; Philipp M; Heidt M; Hehrlein FW; Gardemann A; Katz N
    J Hum Hypertens; 2003 Feb; 17(2):133-8. PubMed ID: 12574792
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
    Moon JY; Jeong KH; Paik SS; Han JJ; Lee SH; Lee TW; Ihm CG; Kim MJ; Chung JH
    Nephron Clin Pract; 2009; 111(2):c110-6. PubMed ID: 19142023
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The genetic polymorphisms of angiotensin converting enzyme insertion/deletion and glioma susceptibility: A meta-analysis.
    Sun M; Fang Y; Ma S; Gao X; Sun Y
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320963939. PubMed ID: 33045911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective evaluation of the angiotensin-converting enzyme D/I polymorphism and left ventricular remodeling in the 'Healing and Early Afterload Reducing Therapy' study.
    Zee RY; Solomon SD; Ajani UA; Pfeffer MA; Lindpaintner K;
    Clin Genet; 2002 Jan; 61(1):21-5. PubMed ID: 11903350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demystifying the ACE polymorphism: from genetics to biology.
    Castellon R; Hamdi HK
    Curr Pharm Des; 2007; 13(12):1191-8. PubMed ID: 17504229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-converting enzyme insertion/deletion polymorphism and systemic lupus erythematosus: a metaanalysis.
    Lee YH; Rho YH; Choi SJ; Ji JD; Song GG
    J Rheumatol; 2006 Apr; 33(4):698-702. PubMed ID: 16583472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.
    Zivko M; Kusec R; Galesić K
    Coll Antropol; 2013 Sep; 37(3):765-70. PubMed ID: 24308214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of pharmacogenetic testing to predict treatment response to angiotensin-converting enzyme inhibitor.
    Costa-Scharplatz M; van Asselt AD; Bachmann LM; Kessels AG; Severens JL
    Pharmacogenet Genomics; 2007 May; 17(5):359-68. PubMed ID: 17429318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition.
    Harrap SB; Tzourio C; Cambien F; Poirier O; Raoux S; Chalmers J; Chapman N; Colman S; Leguennec S; MacMahon S; Neal B; Ohkubo T; Woodward M;
    Hypertension; 2003 Sep; 42(3):297-303. PubMed ID: 12925557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiotensin-converting enzyme insertion/deletion gene polymorphism and lung cancer risk: A meta-analysis.
    Wang N; Yang D; Ji B; Li J
    J Renin Angiotensin Aldosterone Syst; 2015 Mar; 16(1):189-94. PubMed ID: 25354524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme gene insertion/deletion polymorphism in migraine patients.
    Tronvik E; Stovner LJ; Bovim G; White LR; Gladwin AJ; Owen K; Schrader H
    BMC Neurol; 2008 Mar; 8():4. PubMed ID: 18366776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.